References
- Prieto-Gonzalez S, Grau JM. Diagnosis and classification of granulomatous myositis. Autoimmun Rev 2014;13:372–4.
- Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, Perard L, et al. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients. Semin Arthritis Rheum 2017;47:288–94.
- Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A 2005;102:3372–7.
- Celik G, Sen E, Ulger AF, Kumbasar OO, Bozkaya H, Alper D, et al. Sarcoidosis caused by interferon therapy. Respirology 2005;10:535–40.
- Scalco RS, Brady S, Becker J, Gomes I, Holton JL, Staub HL. LETTER TO THE EDITOR Atypical Granulomatous Myositis and Pulmonary Sarcoidosis. Open Rheumatol J 2015 10;9:57–9.
- Le Roux K, Streichenberger N, Vial C, Petiot P, Feasson L, Bouhour F, et al. Granulomatous myositis: a clinical study of thirteen cases. Muscle Nerve 2007;35:171–7.
- Kumamoto T, Yukishige K, Ito T, Nagao S, Mori T, Ueyama H, et al. Cellular distribution of proteolytic enzymes in the skeletal muscle of sarcoid myopathy. Acta Neuropathol 2002;104:38–44.
- Tateyama M, Fujihara K, Itoyama Y. Dendritic cells in muscle lesions of sarcoidosis. Hum Pathol 2011;42:340–6.
- Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 2011;127:315–23.